Affinity Biologicals Overview
- Founded
- 1987

- Status
- Acquired/Merged
- Employees
- 14

- Latest Deal Type
- M&A
- Financing Rounds
- 1
Affinity Biologicals General Information
Description
Manufacturer of products used worldwide in thrombosis and hemostasis research and medical diagnostics. The company's product line includes an extensive line of antibodies to coagulation and hemostasis related proteins, conjugates, antibody pairs for immunoassay of human and animal analytes, ELISA (enzyme-linked immunosorbent assay) kits, and a full line of human plasma products including immune-depleted plasmas, calibrators, and controls, along with services such as protein purification, antibody production, assay development, custom manufacturing, and lyophilization.
Contact Information
(Operating Subsidiary)
- 1348 Sandhill Drive
- Ancaster, Ontario L9G 4V5
- Canada
Affinity Biologicals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore Affinity Biologicals‘s full profile, request access.
Request a free trialAffinity Biologicals Executive Team (2)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Hugh Hoogendoorn | Co Founder, President & Co-Owner | ||
Patricia Hoogendoorn | Co-Founder, Chief Financial Officer & Co-Owner |
Affinity Biologicals Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial